about-me variable
Immucor invites you to their event

ISHI Webinar on July 9 2021

About this event

In his talk, Dr. Böhmig will lay focus on available therapeutic strategies in late antibody-mediated rejection (ABMR). In a deepened discussion of the current literature, he will describe the results of recent systematic trials, such as TRITON, and BORTEJECT, and discuss innovative concepts, such as costimulation blockade, interleukin-6 antagonism and targeting CD38.

Hosted by

  • Team member
    Immucor Inc.


Transfuse. Transplant. Transform a life.

Immucor is a proud partner to thousands of laboratories & donor centers. We are focused on continued innovation in transfusion and transplantation diagnostics.